1. Market Research
  2. > Healthcare Market Trends
Enteral Feeding Formulas Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

Enteral Feeding Formulas Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

  • July 2021
  • 136 pages
  • ID: 6106032
  • Format: PDF
  • Mordor Intelligence LLP
Up to $750 off Until Sep 20th 2021

Summary

Table of Contents

Search Inside

The global enteral feeding formulas market was valued at USD 6,697.08 million in 2020, and it is expected to reach USD 10,069.30 million by 2026, registering a CAGR of 7%, during the forecast period.

The outbreak of COVID-19 is expected to impact the enteral feeding formulas market, as good supportive care remains the cornerstone in managing critically ill patients with COVID-19 infection, within which nutritional management of the ICU admitted COVID-19 patients is an integral component of the supportive measures. According to the research article published in the Society of Critical Care Medicine and the American Society for Parenteral and Enteral Nutrition, 2020, initiating early enteral nutrition (EN) within 24-36 hours of admission to the ICU or within 12 hours of intubation and placement on mechanical ventilation is recommended in the treatment of COVID-19 patients. The publication also suggested that enteral nutrition be preferred over parenteral nutrition.

The enteral feeding formulas market is largely driven by increasing prevalence of metabolic and chronic disorder, increase expenditure on patient care and growing geriatric population. According to the World Heart Federation 2018, coronary heart disease is the leading cause of death worldwide. An estimated 3.8 million men and 3.4 million women die each year from coronary heart disease. In addition, 80% of the deaths occur in low- and middle-income countries. Moreover, rise in the number of premature births, growing nutritional deficiencies, such as severe deficiency of protein and other micronutrients in infants and pregnant women population will drive the demand for nutritional requirement, which ultimately boost the overall market growth.

Also, ageing is the major factor that is driving the market growth for the treatment. According to the United nations department of Economics and Social 2019 report, it was estimated that by the year 2050, one in six people around the world will be over age 65 years old (16%), up from 1 in 11 in the year 2019 (9%). By the year 2050, 1 in 4 persons living in Europe and Northern America could be aged 65 or over that. In the year 2018, for the first time in history, persons aged 65 or above outnumbered children under five years of age globally. The number of persons aged 80 years and above is projected to be the triple, from 143 million in the year 2019 to approximately 426 million in 2050.? Also, according to the article published on National Center for Biotechnology Information 2018, the prevalence of nutrient deficiency in the geriatric population is around 15% in ambulatory outpatients and 35%-65% among hospitalized patients. Thus, the demand for enteral nutrition will rise with the growing geriatric population. Furthermore, the rising healthcare expenditure in developed and developing countries and the increasing demand for home healthcare services will also boost the enteral feeding formulas market growth.

Key Market Trends
Oncology Segment is Expected to Hold a Major Market Share in the Enteral Feeding Formulas Market

The majority of cancer patients suffer from cancer cachexia, which causes insulin resistance, increased lipolysis with loss of body fat, increased protein turnover, and loss of muscle mass, causing loss of appetite and weight.

As per the International Agency for Research on Cancer (IARC) in December 2020, estimated that globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease. IARC estimated that in 2020, the prevalence of cancer has risen to 19.3 million cases and 10 million cancer deaths in 2020, which was around 18 million cancer cases around the world in 2018. With this growing burden, the prevention of cancer is one of the most significant challenges. The cancer burden differs by region. Almost half of the cancer prevalence occurs in Asia, and in Europe, one-quarter of the population is suffering from cancer. Furthermore, to improve the clinical condition of cancer patients, providing nutrition is the cornerstone, as it becomes very difficult for cancer patients to take the food orally. As the treatment proceeds, nutrition is supplied by enteral feeding tubes to enable them to maintain the body mass.

Furthermore, the research presented in the 2020 Virtual Congress on Clinical Nutrition and Metabolism, the annual conference of the European Society for Clinical Nutrition and Metabolism (ESPEN), demonstrated that Kate Farms’ plant-based, oral, enteral formulas (PBEF) can help adult oncology patients maintain or gain weight, allowing them to receive the treatment they need. Hence, the increasing incidence and prevalence of cancer may contribute to the growth of the market studied, during the forecast period.

North America is Expected to Dominate the Market Over the Forecast Period

North America is expected to dominate the enteral feeding formulas market, because of the factors, such as the rapid aging population, the surging prevalence of preterm birth, and the rise in the number of chronic disease patients. According to the Population Reference Bureau’s Population Bulletin Aging in the United States, the Americans aged 65 and older are projected to nearly double from 52 million in 2018 to 95 million by 2060.

The rise in the geriatric population will increase the cases of chronic diseases, such as cancer and diabetes, which will further lead to an increase in the hospital stay of the patient. According to the GLOBOCON 2020, the new cancer cases diagnosed were 2,281,658 in the United States in 2020, with 612,390 deaths. Among all cancers, breast cancer had the highest incidence with 253,465 cases, followed by lung (227,875), prostate (209,512), and colon (101,809) new cancer cases in 2020 in the United States. According to American Hospital Association, Fast Facts on US Hospitals, 2021, 36,241,815 admissions were reported in US Hospitals in 2019, with a total of USD 1,161,032,419,000 expense. Hence, all of the above-mentioned factors are expected to drive the growth of the market.

Competitive Landscape
The enteral feeding formulas market is moderately consolidated. The key market players include Abbott Laboratories, Nestle SA, Danone SA, Fresenius Kabi AG, B. Braun Melsungen AG, Reckitt Benckiser Group plc. (Mead Johnson), Trovita Health Science, Global Health Product Inc., Meiji Holdings Co. Ltd, and Victus, among others.

Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
10% Off

$4250

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on